Users Online: 3826
Home
About us
Editorial board
Ahead of print
Browse Articles
Search
Archives
Submit article
Instructions
Subscribe
Contacts
Login
» Articles published recently
To view other articles click corresponding year from the navigation links on the left side.
All
|
Brief Communication
|
Brief Communications
|
Case Report
|
Case Reports
|
Commentary
|
Corrected and Republished
|
Editorial
|
Editorials
|
Erratum
|
Letter To Editor
|
Letter to Editors
|
Letters to Editor
|
Mini-Review Article
|
Opinion
|
Original Article
|
Original Articles
|
Original Research
|
Retraction Notice
|
Review Article
|
Review Articles
|
Review Protocol
|
Review Study
|
Short Communication
|
Short Communications
|
Systematic Review
|
Systematic Review and Meta.Analysis
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
Brief Communication:
Neuroprotective effects of selegiline agent methamphetamine-prompted mood-related behavior disorder mediated via 5-HT
2
and D
2
receptors
Int J Prev Med
2023, 14:78 (22 June 2023)
DOI
:10.4103/ijpvm.ijpvm_42_22
Background:
Many previous studies demonstrated that methamphetamine (METH) abuses can cause mood-related behavioral changes. Previous studies indicated neuroprotective effects of Selegiline.
Methods:
Seventy male Wistar rats were randomly divided into eight groups (10 rats in each group). Group 1 and Group 2 received normal saline and methamphetamine (10 mg/kg) for 21 days, respectively. Groups 3, 4, and 5 were treated simultaneously with methamphetamine and Selegiline with doses of 10, 15, and 20 mg/kg for 21 days. Groups 6 and 7 are methamphetamine-dependent groups which received 15 mg/kg of Selegiline with haloperidol (as D
2
receptor antagonist) and trazodone (as 5-HT
2
receptor antagonist) for 21 days, respectively. In days 23 and 24, elevated plus maze (EPM) and open-field test (OFT) were conducted to assess motor activity and mood (anxiety and depression) levels.
Results:
METH as 10 mg/kg causes reduction of rearing number, ambulation distances, time spent in central square and also number of central square entries in OFT. Also METH administration causes decreases of time spent in open arm and number of open arm entries and increases of time spent in closed arm and number of closed arm entries in EPM. In contrast, Selegiline (of 10, 15, and 20 mg/kg) inhibited behavioral effects of methamphetamine in both OFT and EPM. Also administration of haloperidol and trazodone inhibited these behavioral protective effects of Selegiline and caused decrease of OFT behaviors (rearing number, ambulation distances, time spent in central square, and also number of central square entries) and also caused decreases of spend times in open arm, number of open arm entries, and also increased closed arm time spending and number of entries in closed arm in EPM.
Conclusions:
Current research showed that Selegiline via mediation of D2 and 5-HT
2
receptors inhibits METH-induced neurobehavioral changes, mood-related behavior, and motor activity disturbances.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Brief Communication:
The "P"-Value: The primary alphabet of research revisited
Int J Prev Med
2023, 14:41 (26 April 2023)
DOI
:10.4103/ijpvm.ijpvm_200_22
Each research roves around the
P
value. A value less than 0.05 is considered to be statistically significant. Very few researchers are aware of the history, real-world significance, statistical insight, and in-depth criticism about this monumental alphabet of research. This article will provide detailed insight into the most common molecule of research which will be rewarding for the young students and researchers in the primary world of research. It is not a simple value; it is the longest and broadest description of research squeezed to a number for the ground level worker to the principal investigator. The present review will provide a detailed and unique insight into the
P
value which would be rewarding for the primary care physicians toward translating research into their clinical practice.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Brief Communication:
Smoking behavior and cigarette expenditure in a household: Evidence for smoke-free houses initiation in Indonesia
Al Asyary, Meita Veruswati
Int J Prev Med
2023, 14:7 (25 January 2023)
DOI
:10.4103/ijpvm.ijpvm_113_21
Background:
The household is considered as a private area that is untouched tobacco control policies in developing countries, especially in Indonesia, which has not ratified the Framework Convention on Tobacco Control (FCTC) treaty.
Objectives:
This study aims to identify smoking behavior and expenditure on cigarettes in the household, which are part of the initiation of a policy including a smoke-free home, so it assumes that the home is a public domain in Tegal Regency, Central Java Province, Indonesia.
Methods:
This research is an observational study with a quantitative descriptive design. A total of 225 subjects in the seven regions designated as smoke-free areas were all selected as samples in this study and were willing to be the subject of research.
Results:
The results found that 76.1% of smokers smoked with their nuclear family (wife/children/husband) present. Smoking behavior with the nuclear family inside the home (39.13%) and outside the home (36.96%) was more common than not smoking with the nuclear family. Expenditure for cigarettes per month was one-third of household revenue (IDR 607,521.74) based on the regency minimum wage (UMR) set by the local government.
Conclusions:
The study concludes that smokers who smoke with family still lack knowledge on smoking's impact on health and household economics. The smoke-free regulation that is initiated should include households as a parameter.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Advanced Search
Month wise articles
Figures next to the month indicate the number of articles in that month
2023
June
[
1
]
April
[
1
]
January
[
1
]
2022
June
[
1
]
April
[
2
]
February
[
1
]
January
[
1
]
2021
December
[
1
]
October
[
1
]
March
[
1
]
2020
September
[
1
]
August
[
1
]
July
[
1
]
June
[
3
]
2019
December
[
1
]
September
[
1
]
July
[
1
]
May
[
2
]
March
[
1
]
2018
November
[
1
]
September
[
1
]
February
[
2
]
2017
September
[
1
]
July
[
1
]
2015
February
[
1
]
Sitemap
|
What's New
Feedback
|
Copyright and Disclaimer
|
Privacy Notice
© International Journal of Preventive Medicine | Published by Wolters Kluwer -
Medknow
Online since 2
nd
January, 2015